FdaApplication
BLA 761045
Identifiers
- fda_app_no: BLA761045
Properties
| Property | Value |
|---|---|
| applicant_name | Sandoz Inc. |
| application_type | BLA |
| approval_date | 2019-11-04 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZIEXTENZO | PEGFILGRASTIM-BMEZ | 6MG/0.6ML | Injection |
1 product